Barbiturate therapy in uncontrolled intracranial hypertension

Area of Science:

• Neurosurgery
• Critical Care Medicine
• Neurology

Background:

• Severe head injuries often lead to uncontrolled intracranial hypertension.
• Patients with poor prognostic indicators present significant management challenges.
• Existing medical and surgical interventions may be insufficient for refractory cases.

Purpose of the Study:

• To evaluate the efficacy of barbiturate therapy in patients with severe head injuries and uncontrolled intracranial hypertension.
• To assess the impact of barbiturate therapy on mortality and patient outcomes.
• To determine if barbiturates can offer a therapeutic option for otherwise untreatable cases.

Main Methods:

• A cohort of 27 patients with severe head injuries and uncontrolled intracranial hypertension were treated with barbiturates.
• Patients received intensive medical and surgical management prior to barbiturate therapy.
• Outcomes including intracranial pressure normalization, mortality, and functional recovery were recorded.

Main Results:

• Barbiturate therapy normalized intracranial pressure in 15 of 27 patients.
• Mortality was 33% in patients who responded to barbiturates versus 75% in non-responders.
• Overall mortality in this selected group was 52%, with 69% of survivors achieving good or moderate recovery.

Conclusions:

• Barbiturate therapy can be effective in managing refractory intracranial hypertension in severe head injuries.
• This treatment may reduce mortality in a highly selected group of critically ill patients.
• Despite high initial morbidity and mortality, barbiturates offer a potential therapeutic avenue for severe head trauma.